ライフサイエンスコーパス: SR-95531

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 yl)-3-amino-6-(4-methoxyphenyl)pyridazinium (SR-95531)].

2 ssed using the GABAA receptor antagonist [3H]SR 95531.

3 modification were decreased both by GABA and SR-95531.

4 K(I) values for the competitive antagonist, SR-95531.

5 s uncoupling by pregnanolone is resistant to SR-95531.

6 Intrastriatal RY 008 (50, 500 ng) and SR 95531 (50 ng) antagonized the sedation produced by th

7 ockade (p = 0.008, using bath-applied 200 nm SR 95531 [6-Imino-3-(4-methoxyphenyl)-1(6H)-p yridazineb

8 a(1)H101C located at the BZD-site, gabazine (SR-95531, a GABA binding site antagonist) decreased the

9 gamma-subunits have little effect on GABA or SR-95531 actions, suggesting that asymmetric motions in

10 esidues are important for mediating GABA and SR-95531 actions.

11 The competitive GABA antagonist SR-95531 and a low, non-activating concentration of pent

12 GABA, SR-95531, and pentobarbital slowed N-biotinylaminoethyl

13 l)pyridazin-1-yl]butanoic acid hydrobromide (SR-95531; antagonist), pentobarbital (allosteric modulat

14 or glycine receptors and our measurements of SR-95531 binding rates.

15 r GABA or pentobarbital but was unaltered by SR-95531 binding, whereas alpha1L127C reactivity was dec

16 The fast unbinding rate of SR-95531 from the glycine receptor will make it useful f

17 by the GABA(A)-R antagonists bicuculline and SR-95531 (gabazine) and increased in frequency and durat

18 The GABA(A) antagonist SR-95531 (gabazine) is known to block glycine receptors,

19 SR-95531 has a fast unbinding rate (k(offSR), about 3000

20 ino-6-(4 methoxyphenyl)pyridazinium bromide (SR-95531), indicating that this arginine poses a barrier

21 tion and converts the competitive antagonist SR-95531 into a partial agonist, demonstrating that this

22 The competitive antagonist SR-95531 inverted this pattern of fluorescence change, b

23 l)-3-amino-6-(4-methoxyphenyl) pyridazinium (SR-95531) K(I) value.

24 In response to GABA (but not SR-95531), labels at the homologous residues in the beta

25 We have studied the effect of SR-95531 on rat recombinant alpha1beta glycine receptors

26 eceptor-mediated transmission application of SR-95531 or bicuculline, while abolishing GABAA receptor

27 also found that equilibrium applications of SR-95531 reduced the response to brief glycine applicati

28 idine-4-sulfonic acid (partial agonist), and SR-95531 sensitivities, indicating that the mutation per

29 of either GABA or the competitive antagonist SR-95531 significantly slows MTSEA-biotin modification o

30 Both GABA and SR-95531 slowed covalent modification of V178C, V180C, a

31 64C, alpha(1)R66C, and alpha(1)S68C, whereas SR-95531 slowed modification of alpha(1)D62C, alpha(1)F6

32 SR 95531, the competitive high-affinity GABAA antagonist

33 one is inhibited by the GABA site antagonist SR-95531, whereas homologous uncoupling by pregnanolone

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。